Veracyte, Inc.
South San Francisco, CA
- UEI
- JS7GBP6LCMN6
- CAGE
- 60GJ7
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
- Veracyte Labs SD Corporation · San Diego, CA DKKCNLTYT2A1
-
- SAM.gov registration date
- Physical address
- 6000 Shoreline Ct #300, South San Francisco, CA 94080, USA
- Website
- veracyte.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $235,600 |
| FY2026 | $1,687,477 |
| FY2025 | $910,377 |
| FY2024 | $756,833 |
| FY2023 | $1,003,187 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $1,923,077 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Natera Inc. | Austin, TX | 621511 Medical Laboratories |
| Prevention Genetics | Marshfield, WI | 621511 Medical Laboratories |
| Karius, Inc. | Redwood City, CA | 621511 Medical Laboratories |
| Neogenomics Laboratories, Inc. | Fort Myers, FL | 541380 Testing Laboratories and Services |
| Konica Minolta Healthcare Americas, Inc., Wayne, NJ | Aliso Viejo, CA | 621511 Medical Laboratories |
About the company
Veracyte, Inc., headquartered in South San Francisco, California, delivers proprietary molecular genomic diagnostic testing services to the Department of Veterans Affairs, Defense Health Agency, Indian Health Service, and the Department of the Navy as a prime contractor on full-and-open delivery orders and indefinite-delivery contracts with no set-aside designations. The company operates as a for-profit corporate entity with one named subsidiary, Veracyte Labs SD Corporation.
Veracyte's federal footprint centers almost entirely on medical laboratory testing services under NAICS 621511 and PSC Q301 (Reference Laboratory Testing). The company's core capability is delivering proprietary molecular diagnostic classifiers—the Afirma Genomic Sequencing Classifier for thyroid nodule malignancy risk stratification and the Decipher Prostate Cancer Test for disease risk assessment—through delivery orders and task orders placed against single-award indefinite-delivery contracts and the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Recent representative contracts include a $1.85 million delivery order from Veterans Integrated Service Network 17 for thyroid molecular genomic testing (January 2026, ultimate completion July 2028), a $412.75 thousand single-award IDIQ from Veterans Integrated Service Network 5 for molecular testing services (March 2026 through March 2031), a $656.9 thousand delivery order from the Indian Health Service for thyroid nodule testing at a military treatment facility (September 2025, ultimate completion September 2030), and a $227.2 thousand delivery order from the Defense Health Agency for Afirma Genomic Sequencing Classifier laboratory testing (October 2023, ultimate completion September 2026).
Customer concentration is dominated by the Department of Veterans Affairs across multiple VISNs. Veterans Integrated Service Network 23 accounts for 33 awards valued at $4.4 million combined potential value; VISN 8 holds 17 awards at $2.5 million; VISN 5 carries 14 awards at $872 thousand; and VISN 16 has 10 awards at $2.3 million. Together, these four VISNs represent 75% of awards by count. By potential value, however, the Department of the Navy Bureau of Medicine and Surgery ranks first at $6.5 million across four orders, followed by VISN 23 at $4.4 million and VISN 8 at $2.5 million—a divergence reflecting the Navy's larger single awards. Veracyte serves 18 distinct federal customer agencies in total.
Veracyte holds multiple single-award IDIQs anchoring task order activity. The primary vehicles include a $2 million IDIQ with VISN 23 running through April 30, 2028 (18 task orders, $1.1 million combined potential value), an $890.64 thousand IDIQ with VISN 16 through September 30, 2029 (five delivery orders placed, thyroid testing focus), and a $412.75 thousand IDIQ with VISN 5 through March 22, 2031. Veracyte also places work against the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule, where 12 task orders carry $3.9 million in combined potential value.
Award activity has remained relatively stable year over year—6 awards in 2022 to 11 in 2026—with 107 total prime awards across the source data window (first award October 2012; most recent August 1, 2026). Seven awards with combined potential value of $3.5 million face ultimate completion inside the next twenty-four months, creating recompete exposure. Combined potential value across all 107 awards stands at $23.7 million, of which $6.5 million (27%) has been obligated to date. Veracyte operates as a pure prime contractor with no subcontract footprint in the source data and carries no small business set-aside designations across its federal portfolio. The company's federal work is performed at its South San Francisco headquarters and at various VA and military treatment facility locations nationwide where testing services are delivered.
Quick answers
Is Veracyte, Inc. registered in SAM.gov?
Yes. Veracyte, Inc.'s SAM.gov registration is active through August 24, 2027.
Which contract vehicles does Veracyte, Inc. hold?
Veracyte, Inc. holds a place on 1 federal contract vehicle: FSS-621-II.
How much has Veracyte, Inc. received in federal contracts?
Federal contracts obligated $910,377 to Veracyte, Inc. in fiscal year 2025 and $4,593,474 in fiscal years 2023 through 2027.
How does Veracyte, Inc. rank among federal contractors?
Veracyte, Inc. ranked #31 in NAICS 621511, #41 in PSC Q515 and #43 in NAICS 6215 in FY2025.
What is Veracyte, Inc.'s most recent federal award?
Veracyte, Inc.'s most recent federal contract award is FY27 task order for veracyte thyroid testing services (36C26327N0064), from Veterans Integrated Service Network 23 (VHA), on October 1, 2026.
On GovTribe
See Veracyte, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors